Changing healthcare isn't a daydream anymore..

Our products promote inclusive and equitable healthcare, enabling patients from across the globe, in remote areas, with any colour of skin to access the critical health care everyone deserves.

Learn More

MIMOSA’s mission is to deliver tissue health imaging technology to drive equity in healthcare.

This equitable approach will save limbs and lives through early detection of tissue compromise.

Origins stories matter...

The MIMOSA Story

MIMOSA Pro provides a proactive approach to skin health, allowing clinicians to implement earlier interventions, or even prevent them from being needed at all. Its genesis and development were driven from personal passion and circumstance.  As a surgeon, our co-founder, Dr. Karen Cross became frustrated at the limited help she could provide as a clinician to help her own Grandfather, living in rural Newfoundland, lost his leg and ultimately his life due to a lack of access to imaging technology to assess his leg.

As a doctor, living in Toronto, Karen could do nothing to help her family to support her Grandfather. This experience emboldened her to change the health care system. She could not do this alone and joined forces with an imaging expert and colleague, Dr. General Leung, also a MIMOSA co-founder. This partnership delivered the MIMOSA Pro device. 

The MIMOSA advantage is that the device is skin pigment, clinical specialty and care setting agnostic, providing equitable access for all clinicians and patients.

Making the invisible... Visible.

Globally Minded, Canadian Based

While our company is dedicated to a global mindset of equity for all peoples, we're proudly developing our MIMOSA devices out of Toronto, Canada - with staff working remotely all across the country & globe!

Made by doctors who understand the problem

Karen Cross, MD, PhD, FRCSC

CEO and Co-Founder
Dr. Karen Cross is a Surgeon Scientist at Dalhousie University and the Innovator in Residence at the Nova Scotia Health Authority (NSHA). She provides expertise and assistance to NSHA to advance innovations in medicine and surgery throughout the continuum of care. She is a Plastic, Reconstructive & Aesthetic Surgeon with a specialization in Advanced Tissue Injury & Wound Care.

General Leung, PhD, MSc

CTO and Co-Founder
Dr. Leung is a Magnetic Resonance physicist. He is currently the Chief Technology Officer at MIMOSA Diagnostics and previously an assistant professor at the University of Toronto in the Department of Medical Imaging. This is his 3rd start-up company.
Meet Some Of Our Amazing Team

“The MIMOSA Pro offers real-time validation, enabling me to gauge the positive impact of our treatment modalities. This insight empowers me to adapt patient care plans proactively, ultimately leading to improved patient outcomes.”

Dr. Matthew Regulski
Medical Director - The Wound Institute of Ocean County

"Having a portable device that could assess tissue compromise and healing potential would be a game changer."

Keith Harding
Senior Clinical Research Director, A*STAR Singapore

"MIMOSA will revolutionize how Podiatrists/Chiropodists manage patients. It will be a great tool in the fight to prevent diabetic foot and vascular complications!"

Nat Rave
Chiropodist (Acute Care & Private Practice), Toronto

"Multispectral and hyperspectral imaging devices are like the modern day TRICORDERS."

David Armstrong
Professor of Surgery, Keck School of Medicine, USC, California, USA